Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2011, Article ID 498460, 10 pages
http://dx.doi.org/10.1155/2011/498460
Research Article

Frequent Loss of Genome Gap Region in 4p16.3 Subtelomere in Early-Onset Type 2 Diabetes Mellitus

1Division of Molecular Metabolism and Diabetes, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan
2CNV Laboratory, DNA Chip Research Institute, 1-1-43 Suehiro-cho, Tsurumi-ku Yokohama, Kanagawa 230-0045, Japan
3Department of Metabolic Diseases, Center for Metabolic Diseases, Tohoku University Graduate School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan

Received 6 October 2010; Revised 21 February 2011; Accepted 30 March 2011

Academic Editor: Kazuya Yamagata

Copyright © 2011 Hirohito Kudo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. M. Frayling, J. C. Evans, M. P. Bulman et al., “beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors,” Diabetes, vol. 50, supplement 1, pp. S94–S100, 2001. View at Google Scholar
  2. J. M. van den Ouweland, H. H. Lemkes, W. Ruitenbeek et al., “Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness,” Nature Genetics, vol. 1, no. 5, pp. 368–371, 1992. View at Google Scholar · View at Scopus
  3. Y. Oka, H. Katagiri, Y. Yazaki, T. Murase, and T. Kobayashi, “Mitochondrial gene mutation in islet-cell-antibody-positive patients who were initially non-insulin-dependent diabetics,” The Lancet, vol. 342, no. 8870, pp. 527–528, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Inoue, Y. Tanizawa, J. Wasson et al., “A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome),” Nature Genetics, vol. 20, no. 2, pp. 143–148, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Kaprio, J. Tuomilehto, M. Koskenvuo et al., “Concordance for Type 1 (insulin-dependent) and Type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland,” Diabetologia, vol. 35, no. 11, pp. 1060–1067, 1992. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Poulsen, K. O. Kyvik, A. Vaag, and H. Beck-Nielsen, “Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance—a population-based twin study,” Diabetologia, vol. 42, no. 2, pp. 139–145, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. J. B. Meigs, L. A. Cupples, and P. W. Wilson, “Parental transmission of type 2 diabetes: the Framingham Offspring Study,” Diabetes, vol. 49, no. 12, pp. 2201–2207, 2000. View at Google Scholar · View at Scopus
  8. C. F. Weijnen, S. S. Rich, J. B. Meigs, A. S. Krolewski, and J. H. Warram, “Risk of diabetes in siblings of index cases with Type 2 diabetes: implications for genetic studies,” Diabetic Medicine, vol. 19, no. 1, pp. 41–50, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. S. F. Grant, G. Thorleifsson, I. Reynisdottir et al., “Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes,” Nature Genetics, vol. 38, no. 3, pp. 320–323, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. H. Unoki, A. Takahashi, T. Kawaguchi et al., “SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations,” Nature Genetics, vol. 40, no. 9, pp. 1098–1102, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Yasuda, K. Miyake, Y. Horikawa et al., “Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus,” Nature Genetics, vol. 40, no. 9, pp. 1092–1097, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Saxena, B. F. Voight, V. Lyssenko et al., “Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels,” Science, vol. 316, no. 5829, pp. 1331–1336, 2007. View at Publisher · View at Google Scholar
  13. L. J. Scott, K. L. Mohlke, L. L. Bonnycastle et al., “A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants,” Science, vol. 316, no. 5829, pp. 1341–1345, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Sladek, G. Rocheleau, J. Rung et al., “A genome-wide association study identifies novel risk loci for type 2 diabetes,” Nature, vol. 445, no. 7130, pp. 881–885, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Steinthorsdottir, G. Thorleifsson, I. Reynisdottir et al., “A variant in CDKAL1 influences insulin response and risk of type 2 diabetes,” Nature Genetics, vol. 39, no. 6, pp. 770–775, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Zeggini, M. N. Weedon, C. M. Lindgren et al., “Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes,” Science, vol. 316, no. 5829, pp. 1336–1341, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. I. Prokopenko, M. I. McCarthy, and C. M. Lindgren, “Type 2 diabetes: new genes, new understanding,” Trends in Genetics, vol. 24, no. 12, pp. 613–621, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Zeggini, L. J. Scott, R. Saxena et al., “Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes,” Nature Genetics, vol. 40, no. 5, pp. 638–645, 2008. View at Publisher · View at Google Scholar
  19. J. R. Lupski, “Genomic rearrangements and sporadic disease,” Nature Genetics, vol. 39, no. 7s, pp. S43–S47, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. D. F. Conrad, D. Pinto, R. Redon et al., “Origins and functional impact of copy number variation in the human genome,” Nature, vol. 464, no. 7289, pp. 704–712, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Park, J. I. Kim, Y. S. Ju et al., “Discovery of common Asian copy number variants using integrated high-resolution array CGH and massively parallel DNA sequencing,” Nature Genetics, vol. 42, no. 5, pp. 400–405, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. A. J. Sharp, D. P. Locke, S. D. McGrath et al., “Segmental duplications and copy-number variation in the human genome,” American Journal of Human Genetics, vol. 77, no. 1, pp. 78–88, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. G. M. Cooper, T. Zerr, J. M. Kidd, E. E. Eichler, and D. A. Nickerson, “Systematic assessment of copy number variant detection via genome-wide SNP genotyping,” Nature Genetics, vol. 40, no. 10, pp. 1199–1203, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Redon, S. Ishikawa, K. R. Fitch et al., “Global variation in copy number in the human genome,” Nature, vol. 444, no. 7118, pp. 444–454, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Seino, K. Nanjo, N. Tajima et al., “Report of the committee on the classification and diagnostic criteria of diabetes mellitus,” Journal of the Japan Diabetes Society, vol. 53, no. 6, pp. 450–467, 2010. View at Google Scholar
  26. H. Stefansson, D. Rujescu, S. Cichon et al., “Large recurrent microdeletions associated with schizophrenia,” Nature, vol. 455, no. 7210, pp. 232–236, 2008. View at Publisher · View at Google Scholar
  27. M. T. Barrett, A. Scheffer, A. Ben-Dor et al., “Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 51, pp. 17765–17770, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. G. H. Perry, A. Ben-Dor, A. Tsalenko et al., “The fine-scale and complex architecture of human copy-number variation,” American Journal of Human Genetics, vol. 82, no. 3, pp. 685–695, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. A. J. de Smith, A. Tsalenko, N. Sampas et al., “Array CGH analysis of copy number variation identifies 1284 new genes variant in healthy white males: implications for association studies of complex diseases,” Human Molecular Genetics, vol. 16, no. 23, pp. 2783–2794, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. A. J. Sharp, S. Hansen, R. R. Selzer et al., “Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome,” Nature Genetics, vol. 38, no. 9, pp. 1038–1042, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. J. R. Lupski, “Genomic disorders ten years on,” Genome Medicine, vol. 1, no. 4, p. 42, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Ionita-Laza, A. J. Rogers, C. Lange, B. A. Raby, and C. Lee, “Genetic association analysis of copy-number variation (CNV) in human disease pathogenesis,” Genomics, vol. 93, no. 1, pp. 22–26, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Shtir, R. Pique-Regi, K. Siegmund, J. Morrison, F. Schumacher, and P. Marjoram, “Copy number variation in the Framingham Heart Study,” BioMed Central Proceedings, vol. 3, supplement 7, p. S133, 2009. View at Google Scholar
  34. The Wellcome Trust Case Control Consortium, “Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls,” Nature, vol. 464, no. 7289, pp. 713–720, 2010. View at Publisher · View at Google Scholar
  35. International Human Genome Sequencing Consortium, “Finishing the euchromatic sequence of the human genome,” Nature, vol. 431, no. 7011, pp. 931–945, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. E. E. Eichler, J. Flint, G. Gibson et al., “Missing heritability and strategies for finding the underlying causes of complex disease,” Nature Reviews Genetics, vol. 11, no. 6, pp. 446–450, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. C. M. Lese, J. A. Fantes, H. C. Riethman, and D. H. Ledbetter, “Characterization of physical gap sizes at human telomeres,” Genome Research, vol. 9, no. 9, pp. 888–894, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. E. E. Eichler, R. A. Clark, and X. She, “An assessment of the sequence gaps: unfinished business in a finished human genome,” Nature Reviews Genetics, vol. 5, no. 5, pp. 345–354, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Devriendt and J. R. Vermeesch, “Chromosomal phenotypes and submicroscopic abnormalities,” Human genomics, vol. 1, no. 2, pp. 126–133, 2004. View at Google Scholar · View at Scopus
  40. G. Van Buggenhout, C. Melotte, B. Dutta et al., “Mild Wolf-Hirschhorn syndrome: micro-array CGH analysis of atypical 4p16.3 deletions enables refinement of the genotype-phenotype map,” Journal of Medical Genetics, vol. 41, no. 9, pp. 691–698, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Itsara, G. M. Cooper, C. Baker et al., “Population analysis of large copy number variants and hotspots of human genetic disease,” American Journal of Human Genetics, vol. 84, no. 2, pp. 148–161, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. D. A. Swartz, E. I. Park, W. J. Visek, and J. Kaput, “The e subunit gene of murine FF-ATP synthase. Genomic sequence, chromosomal mapping, and diet regulation,” Journal of Biological Chemistry, vol. 271, no. 34, pp. 20942–20948, 1996. View at Publisher · View at Google Scholar · View at Scopus
  43. T. Hayakawa, M. Noda, K. Yasuda et al., “Ethidium bromide-induced inhibition of mitochondrial gene transcription suppresses glucose-stimulated insulin release in the mouse pancreatic beta-cell cell line betaHC9,” Journal of Biological Chemistry, vol. 273, no. 32, pp. 20300–20307, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Abderrahmani, G. Niederhauser, V. Plaisance et al., “Complexin I regulates glucose-induced secretion in pancreatic beta-cells,” Journal of Cell Science, vol. 117, no. 11, pp. 2239–2247, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Dubois, P. Vacher, B. Roger et al., “Glucotoxicity inhibits late steps of insulin exocytosis,” Endocrinology, vol. 148, no. 4, pp. 1605–1614, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Kanaoka, S. H. Kimura, I. Okazaki, M. Ikeda, and H. Nojima, “GAK: a cyclin G associated kinase contains a tensin/auxilin-like domain,” Federation of European Biochemical Societies Letters, vol. 402, no. 1, pp. 73–80, 1997. View at Publisher · View at Google Scholar · View at Scopus
  47. S. H. Kimura, H. Tsuruga, N. Yabuta, Y. Endo, and H. Nojima, “Structure, expression, and chromosomal localization of human GAK,” Genomics, vol. 44, no. 2, pp. 179–187, 1997. View at Publisher · View at Google Scholar · View at Scopus
  48. F. Y. Wei, K. Nagashima, T. Ohshima et al., “Cdk5-dependent regulation of glucose-stimulated insulin secretion,” Nature Medicine, vol. 11, no. 10, pp. 1104–1108, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Ubeda, J. M. Rukstalis, and J. F. Habener, “Inhibition of cyclin-dependent kinase 5 activity protects pancreatic beta cells from glucotoxicity,” Journal of Biological Chemistry, vol. 281, no. 39, pp. 28858–28864, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. K. Kitani, S. Oguma, T. Nishiki et al., “A Cdk5 inhibitor enhances the induction of insulin secretion by exendin-4 both in vitro and in vivo,” Journal of Physiological Sciences, vol. 57, no. 4, pp. 235–239, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. A. H. Talukder, Q. Meng, and R. Kumar, “CRIPak, a novel endogenous Pak1 inhibitor,” Oncogene, vol. 25, no. 9, pp. 1311–1319, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. Z. Wang, E. Oh, and D. C. Thurmond, “Glucose-stimulated Cdc42 signaling is essential for the second phase of insulin secretion,” Journal of Biological Chemistry, vol. 282, no. 13, pp. 9536–9546, 2007. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Wiedemann and B. Trueb, “Characterization of a novel protein (FGFRL1) from human cartilage related to FGF receptors,” Genomics, vol. 69, no. 2, pp. 275–279, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. A. A. Hardikar, B. Marcus-Samuels, E. Geras-Raaka, B. M. Raaka, and M. C. Gershengorn, “Human pancreatic precursor cells secrete FGF2 to stimulate clustering into hormone-expressing islet-like cell aggregates,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 12, pp. 7117–7122, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Arnaud-Dabernat, M. Kritzik, A. G. Kayali et al., “FGFR3 is a negative regulator of the expansion of pancreatic epithelial cells,” Diabetes, vol. 56, no. 1, pp. 96–106, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. S. D. Gerber, F. Steinberg, M. Beyeler, P. M. Villiger, and B. Trueb, “The murine Fgfrl1 receptor is essential for the development of the metanephric kidney,” Developmental Biology, vol. 335, no. 1, pp. 106–119, 2009. View at Publisher · View at Google Scholar · View at Scopus
  57. C. M. Sadek, S. Jalaguier, E. P. Feeney et al., “Isolation and characterization of AINT: a novel ARNT interacting protein expressed during murine embryonic development,” Mechanisms of Development, vol. 97, no. 1-2, pp. 13–26, 2000. View at Publisher · View at Google Scholar · View at Scopus
  58. C. M. Sadek, M. Pelto-Huikko, M. Tujague, K. R. Steffensen, M. Wennerholm, and J. A. Gustafsson, “TACC3 expression is tightly regulated during early differentiation,” Gene Expression Patterns, vol. 3, no. 2, pp. 203–211, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Qiu, Y. H. Ni, R. H. Chen et al., “Gene expression profiles of adipose tissue of obese rats after central administration of neuropeptide Y-Y5 receptor antisense oligodeoxynucleotides by cDNA microarrays,” Peptides, vol. 29, no. 11, pp. 2052–2060, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. C. Vernochet, S. B. Peres, K. E. Davis et al., “C/EBPalpha and the corepressors CtBP1 and CtBP2 regulate repression of select visceral white adipose genes during induction of the brown phenotype in white adipocytes by peroxisome proliferator-activated receptor gamma agonists,” Molecular and Cellular Biology, vol. 29, no. 17, pp. 4714–4728, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. R. Simon, T. Lufkin, and A. D. Bergemann, “Homeobox gene Sax2 deficiency causes an imbalance in energy homeostasis,” Developmental Dynamics, vol. 236, no. 10, pp. 2792–2799, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. T. Kato, M. Emi, H. Sato et al., “Segmental copy-number gain within the region of isopentenyl diphosphate isomerase genes in sporadic amyotrophic lateral sclerosis,” Biochemical and Biophysical Research Communications, vol. 402, no. 2, pp. 438–442, 2010. View at Publisher · View at Google Scholar